Business News • MarketWire • NuVasive Prices $350 Million Convertible Senior Notes Due 2017 |
NuVasive Prices $350 Million Convertible Senior Notes Due 2017 |
|
|
NuVasive Prices $350 Million Convertible Senior Notes Due 2017
SAN DIEGO, CA--(Marketwire - Jun 22, 2011) - NuVasive, Inc. (NASDAQ: NUVA) (the "Company"), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced the pricing of $350 million principal amount of 2.75% Convertible Senior Notes due 2017 (the "notes") in an underwritten public offering. NuVasive has also granted the underwriters an option to purchase up to $52.5 million of additional notes solely to cover over-allotments. The offering is scheduled to close on Tuesday, June 28, 2011, subject to satisfaction of customary closing conditions. BofA Merrill Lynch and Goldman, Sachs & Co. are acting as joint book-running managers for the offering.
View More : http://www.marketwire.com/mw/release.do?id=1530461&sourceType=3
|
|
|